Efficient proton adaptive breast radiotherapy with CBCT-Based synthetic CT
In brief
Synthetic CT tracked breast proton dose within 1% of repeat CT
In 26 patients, two synthetic CT methods estimated breast or chest-wall target coverage within about 1% of same-day repeat CT measurements. Weekly virtual CT monitoring was also feasible in 25 additional patients and could flag changes for targeted repeat imaging and replanning, reducing routine repeat scans. Nodal estimates were less reliable because of shoulder image artifacts, and repeat CT remains necessary for accurate dose calculations.
- Journal
- Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) (Q2)
- Published
- 13 November 2026
- Study design
- Cohort / observational study
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- Emma Viviers, Julie A Bradley, Christina Klassen, Raymond Mailhot Vega, Nancy Mendenhall, Mark Artz, et al.
- PMID
- 43025351
- DOI
- 10.1016/j.ejmp.2026.107231
Why clinicians should know about it
- Picked for Medical Physics (top studies of the week, 15 November 2026): Proton adaptive dosimetry validates CBCT synthetic CT against repeat CT
Abstract
PURPOSE: Repeat CTs (reCTs) are routinely used during breast proton radiotherapy to assess anatomical and positioning changes; however, they increase patient dose and workflow burden. This study evaluated CBCT-based synthetic CT imaging for accurately monitoring fractional dose distribution and developed an adaptive workflow for breast proton therapy. METHODS: A retrospective analysis included 26 breast cancer patients who received both CBCT and reCT on the same day between 2022 and 2024. Two commercial synthetic CT algorithms were studied: corrected CBCT (corrCBCT), which utilizes iterative correction, and virtual CT (vCT), generated by deforming the planning CT to match the CBCT. Treatment plans were recalculated on the corrCBCT and vCT, and compared with same-day reCT metrics. A prospective evaluation of weekly vCT-guided dosimetry was performed in an additional 25 patients to assess its feasibility in adaptive workflows. RESULTS: CorrCBCT and vCT produced reliable dosimetric results when compared with reCT. Target coverage, measured by the mean percentage dose difference in D95% to the breast or chest wall, was -0.80% (SD = 1.3) for the corrCBCT and -0.7% (SD = 1.6) for the vCT. vCT also showed good agreement with same-day reCT imaging for dose metrics of adjacent critical structures. Larger discrepancies were observed in nodal targets, primarily due to CBCT image artifacts in the shoulder region. CONCLUSION: Accurate proton-dose calculations require reCT, but synthetic CT can effectively flag tissue alterations. This study shows that monitoring dosimetric shifts from vCT can prompt targeted reCT-based replanning in unilateral breast proton therapy, thereby sparing patients the exposure and logistics of routine reCT during treatment.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.